Randal J Kirk's Net Worth
$281 Million
Who is Randal J Kirk?
Randal J Kirk has an estimated net worth of $281 Million. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, NEW RIVER PHARMACEUTICALS INC, HISTOGENICS CORP, AquaBounty Technologies, Inc., AmpliPhi Biosciences Corp, PRECIGEN, INC., SOLIGENIX, INC., Synthetic Biologics, Inc., Fibrocell Science, Inc., ORAGENICS INC, HALOZYME THERAPEUTICS INC, TRANSGENOMIC INC, and CLINICAL DATA INC.
SEC CIK
Randal J Kirk's CIK is 0001091823
Past Insider Trading and Trends
2008 was Randal J Kirk's most active year for acquiring shares with 5 total transactions. Randal J Kirk's most active month to acquire stocks was the month of April. 2006 was Randal J Kirk's most active year for disposing of shares, totalling 4 transactions. Randal J Kirk's most active month to dispose stocks was the month of March. 2008 saw Randal J Kirk paying a total of $6,999,997.45 for 679,601 shares, this is the most they've acquired in one year. In 2011 Randal J Kirk cashed out on 2,538,776 shares for a total of $72,676,536.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +14.07% | 17.2K |
—
|
—
| 139.51K |
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +27.87% | 26.66K |
—
|
—
| 122.31K |
Dec 31
| |||
Form 4
| -50.10% | -9.61M |
—
|
—
| 9.57M |
Jun 4
| |||
Form 4
| +8.79% | 1.44M |
$8.75 | $12,600,000.00 | 17.83M |
Feb 9
| |||
Form 4
| +21.16% | 16.71K |
—
|
—
| 95.65K |
Dec 31
| |||
Form 4
| +31.30% | 18.82K |
—
|
—
| 78.94K |
Dec 31
| |||
Form 4
| +21.11% | 2.86M |
$3.50 | $10,000,000.50 | 16.39M |
Oct 29
| |||
Form 4
| +41.21% | 17.55K |
—
|
—
| 60.12K |
Dec 31
| |||
Form 4
| +36.75% | 3.64M |
—
|
—
| 13.53M |
Nov 7
| |||
Form 4
| +24.12% | 1.92M |
$5.20 | $9,999,990.00 | 9.9M |
Jan 20
| |||
Form 4
| +70.31% | 17.58K |
—
|
—
| 42.58K |
Dec 30
| |||
Form 4
| +2.93% | 38.29K |
$4.99 | $191,087.06 | 1.35M |
Aug 23
| |||
Form 4
| +54.53% | 461.65K |
$4.92 | $2,272,820.98 | 1.31M |
Aug 18 - Aug 22
| |||
Form 4
|
∞
| 846.52K |
$4.78 | $4,042,233.50 | 846.52K |
Aug 5 - Aug 9
| |||
Form 4
| +31.50% | 1.91M |
$5.75 | $10,982,500.00 | 7.97M |
Feb 3
| |||
Form 4
| +250.93% | 6.09M |
$4.80 | $11,645,928.00 | 8.51M |
Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEW RIVER PHARMACEUTICALS INC No price found
Chairman, President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| -5.77% | -1.00M |
$48.71 | -$48,705,029.94 | 16.32M |
Nov 9 - Nov 10
| |||
Form 4
| -4.33% | -887.00K |
$33.50 | -$29,714,500.00 | 19.6M |
Apr 19
| |||
Form 4
| +0.42% | 10K |
$3.33 | $33,300.00 | 2.38M |
Mar 22
| |||
Form 4
| -0.85% | -176.00K |
$30.02 | -$5,283,586.89 | 20.48M |
Feb 13 - Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| -0.08% | -7.50K |
$49.17 | -$368,750.24 | 9.13M |
Scheduled
|
Dec 19
| ||
Form 4
| -3.80% | -380.00K |
$47.80 | -$18,163,545.20 | 9.63M |
Scheduled
|
Dec 14 - Dec 16
| ||
Form 4
| -0.35% | -35.00K |
$47.48 | -$1,661,694.00 | 10.01M |
Scheduled
|
Dec 9 - Dec 13
| ||
Form 4
| -0.52% | -52.00K |
$48.99 | -$2,547,428.00 | 10.04M |
Scheduled
|
Dec 5 - Dec 6
| ||
Form 4
| -1.91% | -187.00K |
$43.24 | -$8,086,570.00 | 9.62M |
Scheduled
|
Sep 15 - Sep 19
| ||
Form 4
| -3.00% | -303.34K |
$41.28 | -$12,522,308.20 | 9.81M |
Scheduled
|
Sep 9 - Sep 12
| ||
Form 4
| -0.26% | -23.24K |
$41.69 | -$969,014.85 | 9.04M |
Scheduled
|
Sep 2 - Sep 6
| ||
Form 4
| -0.09% | -11.92K |
$41.78 | -$498,571.58 | 13.69M |
Scheduled
|
Sep 1 - Sep 6
| ||
Form 4
| -13.52% | -187.00K |
$30.00 | -$5,610,000.00 | 1.2M |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
| +23.50% | 325K |
$8.00 | $2,600,000.00 | 1.71M |
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HISTOGENICS CORP (OCGN) Snapshot price: $1.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -37.10% | -1.00M |
$0.16 | -$158,771.67 | 1.69M |
Jan 11 - Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AquaBounty Technologies, Inc. (AQB) Snapshot price: $0.9595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -71.29% | -12.88M |
$2.10 | -$27,048,000.00 | 5.19M |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -5.72% | -34.09K |
—
|
—
| 561.84K |
Dec 17
| |||
Form 4
| +77.29% | 4M |
$2.50 | $10,000,000.00 | 9.18M |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
∞
| 5.17M |
$1.50 | $7,762,500.00 | 5.17M |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +22.96% | 1.54M |
$2.00 | $3,076,922.00 | 8.24M |
Oct 25
| |||
Form 4
| +29.80% | 1.54M |
$3.25 | $4,999,998.25 | 6.7M |
Jan 17
| |||
Form 4
| -22.24% | -92.98K |
—
|
—
| 325.13K |
Jul 24
| |||
Form 4
| +34.87% | 1.58M |
$10.33 | $25,009,684.09 | 6.09M |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AmpliPhi Biosciences Corp (ARMP) Snapshot price: $2.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.15% | -177.02K |
$0.48 | -$84,375.40 | 1.41M |
Dec 27 - Dec 29
| |||
Form 4
| +107.14% | 428.57K |
—
|
—
| 828.57K |
Nov 12
| |||
Form 4
| +58.08% | 13.94M |
$0.17 | $2,299,999.68 | 37.94M |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||